Tigard, OR · Founded 2020 · Privately Held (backing)
Developer of advanced imaging technologies intended to enhance the drug discovery process for researchers. Araceli Biosciences is based in Tigard, OR and was founded in 2020. It was valued at $27 million at its seed round in Nov 2025, the last priced event on record. It has raised $14.5 million across 2 recorded rounds; the latest was a $12.2 million early-stage round in Dec 2024.
PMV mark · valuation
$27.0M
Oct 2026
Priced at
its seed round
Nov 2025
Total raised
$14.5M
Last round
Early Stage VC
Dec 2024
Cap table — not yet on record
Araceli Biosciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Araceli Biosciences with a free account
·Watch Araceli Biosciences: the Monday email on marks, rounds and moves
Where does Araceli Biosciences's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Araceli Biosciences's 2 recorded funding rounds.
